Bar Vac 7/SomnusThis page contains information on Bar Vac 7/Somnus for veterinary use.
The information provided typically includes the following:
- Bar Vac 7/Somnus Indications
- Warnings and cautions for Bar Vac 7/Somnus
- Direction and dosage information for Bar Vac 7/Somnus
Bar Vac 7/SomnusThis treatment applies to the following species:
Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C & D-Haemophilus Somnus Bacterin-Toxoid
U.S. Vet. Lic. No.: 124
CompositionPrepared from cultures of the organisms listed. Alum precipitated.
Bar Vac 7/Somnus Indications
Recommended for the vaccination of healthy, susceptible cattle against diseases caused by Clostridium chauvoei, Cl. septicum, Cl. novyi, Cl. sordellii, Cl. perfringens Types C and D and Haemophilus somnus. Although Clostridium perfringens Type B is not a significant problem in the U.S.A., immunity may be provided against the beta and epsilon toxins elaborated by Clostridium perfringens Type B. This immunity is derived from the combination of Type C (beta) and Type D (epsilon) fractions.
Dosage and AdministrationUsing aseptic technique, inject 5 mL subcutaneously. Repeat in 21 to 28 days and once annually.
Precaution(s): Store out of direct sunlight at a temperature between 35-45°F (2-7°C). Avoid freezing. Shake well before using. Use entire contents when first opened.
Caution(s): Transient swelling at the injection site may occur. Anaphylactoid reactions may occur.
Antidote(s): Administer epinephrine.
Warning(s): Do not vaccinate within 21 days before slaughter.
18701-03 / 18702-03 / 18703-03
Presentation: 10 doses (50 mL), 50 doses (250 mL), and 200 doses (500 mL).
NAC No.: 10280091
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
|Every effort has been made to ensure the accuracy of the Bar Vac 7/Somnus information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-04-21